Healthy adults help uncover how two drugs interact
NCT ID NCT07071532
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This early-stage study looks at how a new drug called ABBV-932 moves through the body when taken with another drug, itraconazole. Twenty healthy adults will take both drugs and have their blood levels measured. The goal is to check for side effects and see if itraconazole changes how ABBV-932 is processed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ABBV-932 and itraconazole
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Acpru /Id# 276951
Grayslake, Illinois, 60030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- Can a web app get people moving in mental health residential care?
- Smartwatch data may forecast bipolar mood swings
- Could a talking therapy ease the weight of bipolar depression?
- First look: can a new drug candidate pass early safety tests in humans?